Adrenaline Usage to Reduce Blood Transfusions Following Hip Fracture Surgery: A Randomised Clinical Study.

ISRCTN ISRCTN17472370
DOI https://doi.org/10.1186/ISRCTN17472370
Secondary identifying numbers N0265041838
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
14/03/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr D Clark
Scientific

Trauma
Selly Oak Hospital
Birmingham
B29 6JD
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeNot Specified
Scientific title
Study objectivesOur hypothesis is that by using intraoperative swabs soaked in an adrenaline solution we will decrease surgical blood loss and hence decrease the need for postoperative and intraoperative blood transfusion.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Hip fracture
InterventionRandomly allocated to two groups (32 patients per group):
Group A: Wound site infiltrated with 10mls 0.5% marcain with adrenaline.
Group B: All swabs used intraoperatively soaked in a solution made up of 5 mg of adrenaline in 1 litre N/Saline.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Adrenaline
Primary outcome measureMeasured reduction in postoperative and interoperative blood loss.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2004
Completion date01/01/2007

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants64
Key inclusion criteriaPatients with fracture of the proximal femur requiring Dynamic Hip Screw fixation.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2004
Date of final enrolment01/01/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Trauma
Birmingham
B29 6JD
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

University Hospital Birmingham NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan